Annexon CEO and leadership

Larry Mattheakis is a Chief Scientific Officer at Annexon Biosciences and Senior VP:Discovery Biology & Translational Research at PROTAGONIST THERAPEUTICS INC and is based in Menlo Park, California. He has experience at EXELIXIS INC and has worked as Director:Biology at PROTAGONIST THERAPEUTICS INC. Larry attended UNIVERSITY OF CALIFORNIA SAN and University of Wisconsin Madison.

Jennifer Lew is an EVP & Chief Financial Officer at Annexon Biosciences and is based in Danville, California. She has worked as Director:Finance at QRS, Assistant Controller at QRS, and Senior Director & Corporate Controller at DYNAVAX TECHNOLOGIES CORP. Jennifer studied at Claremont McKenna College between 1990 and 1994.

I lead the Corporate Strategy and Six Sigma organizations at Lilly with the responsibility for the development our overall company strategy and the implementation of our key corporate initiatives. I also serve as the Secretary for Lilly's Executive Committee.

Most recently, Yednock was the Chief Scientific Officer of Neotope Biosciences, the pre-clinical therapeutic antibody-focused unit of Elan that was spun-out to shareholders as Prothena. Previously, he was Executive Vice President and the Head of Global Research for Elan Pharmaceuticals. Yednock joined Elan as part of the acquisition of Athena Neurosciences, where he initiated research on multiple sclerosis which led to the development of Tysabri®, a marketed monoclonal antibody with 2011 sales exceeding $1.5 billion. Yednock has contributed to the invention or progression of more than a dozen drugs in the areas of rheumatoid arthritis, Crohn’s disease, pain and Alzheimer’s disease, in addition to his work in multiple sclerosis. He has been involved in collaborations with Biogen-Idec, Wyeth/Genetics Institute, Johnson & Johnson, the Michael J. Fox Foundation, the Alzheimer’s Drug Discovery Foundation and the Parkinson’s Institute, among others. Yednock earned his B.S. in Biology and Chemistry from the University of Illinois and his Ph.D. in Anatomy and Cell Biology from UCSF, where he also completed postdoctoral fellowships in Anatomy and Cell Biology and Immunology/Microbiology.